13.70
-1.02
(-6.93%)
At close: 3:04:33 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jian Fei Qin | Chairman & President | -- | -- | 1963 |
Mr. Zhicheng Zhao | Financial Director | -- | -- | 1975 |
Mr. Yan Fei Liang | VP, Board Secretary & Director | -- | -- | 1967 |
Harbin Medisan Pharmaceutical Co., Ltd.
Beijing Road
Limin Development Zone
Harbin, 150025
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 2,115
Description
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical product and medical devices in China. The company offers various drugs for nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective, basic infusions, nutritional infusion, anti-tumor and immunomodulators, digestive tract, metabolism, etc. It also produces and sells cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.
Corporate Governance
Harbin Medisan Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 5, 2024 at 12:00 AM UTC
Ex-Dividend Date